Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1214717 BOSTON, MA
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$80,708
-$35,890 QoQ
Shares Held
19,035
-24.3% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 103 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. BCYC ranks #455 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in BCYC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,708 19,035
2026-03-31 $116,598 25,129
2025-12-31 $177,913 25,129
2025-09-30 $309,019 39,925
2025-06-30 $280,863 40,412
2025-03-31 $181,490 21,377
2024-12-31 $543,410 38,815
2024-09-30 $867,521 38,335
2024-06-30 $432,670 21,377
2024-03-31 $532,287 21,377
2023-12-31 $340,572 18,837
2023-09-30 $344,422 17,144
2023-06-30 $437,514 17,144
2023-03-31 $364,652 17,144
2022-12-31 $507,462 17,144
2022-09-30 $498,229 21,420
2022-06-30 $186,811 11,133
2022-03-31 $488,516 11,133
2021-12-31 $601,395 9,880
2021-09-30 $410,909 9,880
2021-06-30 $227,062 7,479